Miñoza, Danica .
HRN: 23-88-29 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
CEFUROXIME 500MG (TAB)
10/12/2023
10/18/2023
PP
500mg
BID
UTI
Checking Final Appropriateness